National Diabetes News
Nearly Half of Americans Fear They Can’t Afford Care in 2026, Poll Finds
Many Americans are bracing for higher medical costs in the new year and a growing number say those expenses are already shaping their decisions for care, according to a new survey. The latest West Health–Gallup poll, shows that 47% of adults are worried they won’t be able to afford health care in 2026, the highest level since the organizations began tracking these concerns four years ago.
Kidney pharmacy services model associated with better outcomes for patients on dialysis
Patients on hemodialysis, either in a center or at home, who used a specialized kidney pharmacy program had lower mortality and fewer hospitalizations than those who used retail pharmacies, according to study data.
VIDEO: Daily fish oil reduces serious CV event rates for patients receiving hemodialysis
In this video, Jeffrey S. Berns, MD, discusses the results of the PISCES study, presented at ASN Kidney Week, that found daily fish oil supplementation reduced serious cardiovascular event rates for patients receiving hemodialysis.
Do GLP-1 Supplements Work?
When it comes to managing diabetes and weight loss, GLP-1 medications have become a popular option. However, due to high out-of-pocket costs, drug shortages, and the fact that a prescription is needed to obtain these medications, people might be searching for other options. This is where dietary supplements have come into play. Recently, over-the-counter dietary supplements that don’t require a prescription have hit the market, including Kourtney Kardashian’s Lemme GLP-1 Daily, which claims to naturally “boost” GLP-1 levels in the body to reduce hunger and support healthy weight management.
Here’s How CGM Is Transforming Clinical Trials
For decades, clinical trials have played a key role in preventing, managing (and hopefully one day, curing) diabetes. These trials are responsible for developing tools people with diabetes rely on daily – like automated insulin delivery (AID) systems, new medications, behavioral programs, and more.
New weight loss drug, taken once weekly, leads to 20% weight loss in trial
According to the World Obesity Federation, as of 2024, about 3 billion people around the world were overweight or obese. To help in the fight against obesity, medications for weight loss have skyrocketed in popularity over the last few years. A 2024 poll found that about one in eight adults have ever taken a glucagon-like peptide-1 (GLP-1) receptor agonist medication, such as Wegovy or Zepbound. However, not everyone who takes a GLP-1 medication loses weight. Past studies show that as much as 17% of GLP-1 users may be “non-responders” to the medication.
Study suggests type 1 diabetes may significantly raise bladder cancer risk
People with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, according to a systematic review and meta-analysis by researchers at the Keck School of Medicine of USC. The new analysis is the first to control for the effects of tobacco smoking, a factor that likely obscured the heightened risk in earlier studies.
